Clinical value of cell-based assays in the characterisation of seronegative myasthenia gravis
Damato V. et al, (2022), Journal of Neurology, Neurosurgery & Psychiatry, 93, 995 - 1000
Utility of Live Cell-Based Assays for Autoimmune Neurology Diagnostics
Woodhall M. et al, (2022), The Journal of Applied Laboratory Medicine, 7, 391 - 393
Frequency of MOG-IgG in cerebrospinal fluid versus serum
Pace S. et al, (2021), Journal of Neurology, Neurosurgery and Psychiatry
The clinical profile of NMOSD in Australia and New Zealand.
Bukhari W. et al, (2020), J Neurol, 267, 1431 - 1443
Real-world prevalence of autoantibodies in epilepsy
McGinty RN. et al, (2020), EUROPEAN JOURNAL OF NEUROLOGY, 27, 61 - 61
Serial MOG-antibody analyses and outcomes in a prospective unselected cohort of pediatric demyelinating syndromes
WATERS P. et al, (2019), JAMA Neurology